RELIGN is a MedTech Venture Partners portfolio company.

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

From the story at Global Legal Chronicle.

Zimmer Biomet, a leading medical device manufacturer, announced in its earnings report that it has acquired Relign Corp., a privately held start-up in the growing $1.6 billion arthroscopy market and overall $5 billion sports medicine market. Relign’s offerings include the consolidation of three differentiated arthroscopy tower components into a single system, a first in the industry, and address a key portfolio gap for Zimmer Biomet in the sports medicine and broader ambulatory surgery center markets.